The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours

1987 ◽  
Vol 89 (3-4) ◽  
pp. 117-121 ◽  
Author(s):  
C. B. Ostertag ◽  
B. Volk ◽  
T. Shibata ◽  
P. Burger ◽  
P. Kleihues
1989 ◽  
Vol 37 (10) ◽  
pp. 1471-1478 ◽  
Author(s):  
B Falini ◽  
L Flenghi ◽  
M Fagioli ◽  
H Stein ◽  
R Schwarting ◽  
...  

The human proliferation-associated epitope recognized by the Ki-67 monoclonal antibody (MAb) was detected in proliferating normal and neoplastic cells of many mammalian species (lamb, calf, dog, rabbit, rat) besides human. In contrast, Ki-67 stained proliferating cells from other species weakly (mouse) or not at all (swine, cat, chicken, pigeon). The immunostaining pattern of Ki-67 in animal tissues was identical to that previously described in human: Ki-67 reacted only with cells known to proliferate (e.g., germinal center cells, cortical thymocytes) but not with resting cells (e.g., hepatocytes, brain cells, renal cells); this MAb produced a characteristic nuclear staining pattern (e.g., stronger labeling of nucleoli than of the rest of the nuclei and staining of chromosomes in mitotic figures); and Ki-67 crossreacted with the squamous epithelium in both animal and human tissues. In vitro studies showed that when quiescent (Ki-67-negative) NIH 3T3 fibroblasts or bovine peripheral blood lymphocytes were induced to proliferate, the appearance of Ki-67-positive cells paralleled the induction of cell proliferation caused by addition of fetal calf serum or PHA, respectively, to the cultures, and in both human and rat proliferating cells the Ki-67 expression closely paralleled the incorporation of [3H]-thymidine. These findings indicate that the epitope recognized by the Ki-67 MAb in human and animal species is the same. The widespread evolutionary conservation of the human proliferation-associated epitope recognized by the Ki-67 MAb suggests that it and/or its carrier molecule may play an important role in regulation of cell proliferation.


1989 ◽  
Vol 75 (6) ◽  
pp. 557-562 ◽  
Author(s):  
Sergio Crispino ◽  
Ambrogio Brenna ◽  
Daniela Colombo ◽  
Bajardo Flores ◽  
Silvestro D'Amico ◽  
...  

Measurements of cell cycle kinetics have been found to correlate with the clinical course of patients with breast cancer. However, the thymidine labeling index and more rapid methods like flow cytometry remain complicated and costly. We assessed cell proliferation of 67 breast carcinomas by an immunoperoxidase procedure using a monoclonal antibody, Ki-67, which reacts with a nuclear antigen in proliferating cells. The percentage of Ki-67 positive cells ranged from 2% to 70 %. Tumors with high mitotic rate, high nuclear grade, high histologic grade, and negative estrogen receptors had statistically higher Ki-67 labeling rates. We found no significant differences between the Ki-67 labeling rate and other clinical (age at diagnosis, menopausal status) or pathologic (necrosis, fibrosis, vascular invasion, lymphatic invasion, cellular reaction, tumor size, lymph node metastases) features assessed. These results parallel previously reported data, and confirm that this immunohistochemical staining of breast carcinoma by Ki-67 monoclonal antibody can be considered a rapid and convenient method for assessing cell cycle kinetics. However, further studies, evaluating the correlation between Ki-67 labeling rate and prognosis are needed to better define the real usefulness of this analysis in clinical practice.


Neurosurgery ◽  
1989 ◽  
Vol 25 (6) ◽  
pp. 927-930 ◽  
Author(s):  
Engelbert Knosp ◽  
Klaus Kitz ◽  
Axel Perneczky

Abstract The monoclonal antibody (MAb) Ki-67 detects a nuclear antigen expressed by proliferating cells during the entire cell cycle. In contrast to conventional histological techniques, the use of MAb Ki-67 on frozen sections or cytological smear preparations allows direct determination of the growth rate of tumors routinely. Sixty-two pituitary adenomas were investigated by use of the MAb Ki-67 in a two-step avidin-biotin-peroxidase complex technique. The proliferation activity ranged from 0.1 to 2.8%. There was no significant difference between the proliferation and hormonal state of the adenomas. Adenomas for which there was histological evidence of dural infiltration, however, showed a statistically significant higher proliferation activity (P> 0.05) compared to noninvasive adenomas.


Neurosurgery ◽  
1988 ◽  
Vol 22 (2) ◽  
pp. 364-368 ◽  
Author(s):  
Patrick Zuber ◽  
Marie-France Hamou ◽  
Nicolas de Tribolet

Oncology ◽  
1991 ◽  
Vol 48 (2) ◽  
pp. 162-165 ◽  
Author(s):  
Yutaka Yonemura ◽  
Hironobu Kimura ◽  
Shigekazu Ooyama ◽  
Tom Kamata ◽  
Akio Yamaguchi ◽  
...  

1990 ◽  
Vol 1 (6) ◽  
pp. 441-446 ◽  
Author(s):  
Masaaki Ando ◽  
Toshimitsu Kawashima ◽  
Hitoshi Kobayashi ◽  
Akira Ohkawara

Sign in / Sign up

Export Citation Format

Share Document